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EDITORIAL
Diarrhoea continues to be a leading cause of mor-
bidity and mortality around the world, resulting in 
an estimated 1.5 billion episodes and 1.5 million to 
2.2 million deaths annually among children aged 
less than five years (1,2). Oral rehydration therapy 
(ORT) effectively treats mild-to-moderate dehydra-
tion due to diarrhoea and, for the past three dec-
ades, has saved millions of lives, mostly in develop-
ing countries. A crucial aspect in this decrease in 
mortality due to diarrhoea has been the widespread 
acceptance of ORT for the prevention and treat-
ment of dehydration associated with diarrhoeal 
illnesses (3). However, despite its remarkable suc-
cess, the currently-recommended oral rehydration 
solution (ORS) does not significantly reduce stool 
volume or duration of diarrhoeal illness. Thus, the 
search continues for improved formulations of ORS 
capable of lessening the severity of diarrhoea.
The underlying physiologic principle of ORT is 
neat and simple—transport of sodium-coupled 
glucose across the small intestinal epithelial mem-
brane remains largely intact in secretory diarrhoea 
and continues to stimulate absorption of water and 
electrolytes (4). Most attempts towards improving 
ORS have aimed at optimization of absorption of 
small intestinal fluid. Searching for an ORS capable 
of reducing diarrhoeal stool output, many clinical 
and basic scientists have investigated the role of 
other sodium co-transport substrates in addition to 
or instead of glucose. These included adding amino 
acids, e.g. glycine (5), alanine (6), and glutamine (7), 
and substitution of glucose by complex carbohy-
drates, e.g. maltodextrins (8), cooked rice-powder 
and other cereal powders (9,10). While the clinical 
trials using glycine, alanine, maltodextrins, and ce-
real-based ORSs conducted in the 1970s and 1980s 
showed promise, results of subsequent large tri-
als and meta-analyses of results of previous trials 
found no advantage of most of these formulations 
when compared with the WHO-ORS, with the ex-
ception of rice-based ORS (11,12).
In the study published in this issue of the Journal 
of Health, Population and Nutrition, Guiterrez et al. 
compared the effects of a glutamine-containing 
glucose-free ORS with WHO-ORS in a double-blind 
randomized clinical trial among 147 dehydrated 
children with acute diarrhoea (13). Rotavirus was 
isolated from 62 of these children. The authors did 
not observe any significant difference between the 
two ORS groups in stool output during the first four 
hours, time taken to rehydrate successfully, vol-
ume of ORS needed to rehydrate, vomiting, and 
urinary output. This was independent of rotavirus-
associated illness. The authors concluded that an 
L-glutamine-containing glucose-free ORS does not 
seem to offer any clinical benefit compared to the 
standard WHO-ORS in mild-to-moderately dehy-
drated children with acute non-cholera diarrhoea.
The amino acid glutamine is the fundamental res-
piratory fuel for the small intestine and has been 
classified as a conditional essential amino acid (14). 
Supplementation of glutamine has been shown 
to cause marked improvement in gastrointestinal 
structure and function after injury by chemother-
apy, radiotherapy (15,16), or following prolonged 
parenteral nutrition (17). Glutamine also helps 
maintain the intestinal immunologic barrier, since 
it has been shown to increase the intestinal immu-
noglobulin A levels and to reduce bacterial trans-
location (18,19), and possibly the mechanism by 
which it reduces the incidence of bacteraemia and 
clinical infections (15,20). In addition, glutamine 
has also been postulated as a regulator of intracel-
lular kinases, apoptosis, cell proliferation, redox sta-
tus, and heat shock protein expression (21). 
In addition to being the predominant intestinal 
epithelial fuel source, the fact that glutamine is 
able to function as a sodium co-transport substrate 
in an electrogenic manner and to stimulate elec-
troneutral NaCl absorption (22) has generated in-
terest in glutamine as a potentially-useful compo-
nent in ORS. Experiments have clearly shown that 
glutamine is able to promote the absorption of so-
dium and water, even more effectively than glucose 
(23,24). In a perfused rabbit ileum model exposed 
to cholera toxin, a glutamine-based ORS caused a 
reduction of approximately 90% of cholera toxin-
induced net sodium and water secretion (23); these 
observations are supported by other reports (24). JHPN 264
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In a rat model of secretory diarrhoea induced by 
cholera toxin (25), glutamine was found to have 
a significant positive effect upon sodium absorp-
tion, but alanine-glutamine-based ORS had an 
even better effect in sodium absorption.  However, 
it remains to be explained whether these effects of 
alanine-glutamine are due only to effective avail-
ability of glutamine or to a different mechanism. In 
adult cholera patients, in vivo intestinal perfusion 
experiments have shown that glutamine-contain-
ing ORS reduced electrolyte and water secretion, 
although no increased sodium or water absorption 
was observed when compared with the effects with 
ORS containing glucose alone (26). In dehydrated 
infants suffering from non-cholera acute diarrhoea, 
ORS containing glutamine was found to be well-
tolerated and as effective as the standard WHO-ORS 
(7). In another study conducted among adults with 
cholera, use of glutamine-supplemented ORS was 
associated with a 25% reduction in stool volume in 
the first 24 hours and a 30% reduction in the total 
faecal loss (27). Glutamine has also been observed 
to stimulate sodium co-transport in experimental 
models of rotavirus-associated enteritis and entero-
pathogenic Escherichia coli-associated enteritis 
(28,29), although observations from other animal 
studies are not suggestive of a substantial effect of 
glutamine on acute diarrhoea (30).
Investigators, in efforts to enhance the effective-
ness of ORS, have also pursued pathways other 
than optimization of small intestinal absorption. 
One approach has been to use the mechanism of 
colonic salvage of fluids unabsorbed in the small 
intestine. Short-chain fatty acids are the major 
colonic luminal anions and are able to enhance so-
dium absorption and inhibit chloride secretion 
in both normal and secreting colon (31,32). Short-
chain fatty acids are formed in the colon by fer-
mentation of unabsorbed starch and dietary fibres 
by  the  resident  anaerobic  bacterial  flora.  Several 
studies have examined the effects of addition of 
amylase-resistant starch and soluble dietary fibres 
to the standard ORS in diarrhoeal patients. In adult 
cholera patients, the group receiving amylase-re-
sistant starch had had significantly reduced stool 
volumes and the duration of illness when com-
pared with the group receiving the standard WHO-
ORS (33). In non-cholera childhood diarrhoea, two 
studies reported that the addition of amylase-resist-
ant starch or partially-hydrolyzed guar gum (as the 
short-chain fatty acid precursors) to the standard 
glucose-ORS significantly shortened the duration 
of diarrhoea (34,35), whereas another study using 
a mixture of non-digestible carbohydrates failed 
to observe any benefit (36). Taking a different ap-
proach, a group of investigators aimed at ex-
amining  whether  bioactive  proteins  found  in 
breastmilk, when added to the standard ORS, yield 
any additional advantage. They observed that the 
addition of recombinant human lactoferrin and 
lysozyme to a rice-based ORS led to a significant de-
crease in the duration of diarrhoea in children with 
non-cholera acute diarrhoea (37). Yet, in another 
innovative  approach—in  an  experimental  study 
using in vivo small intestinal perfusion in rats ex-
posed to cholera toxin or the 5-fluorouracil—ORS 
with partial incorporation of the ORS components 
into liposomes showed 40-50% increased absorp-
tion of water when compared with that from hypo-
osmolar WHO glucose-ORS (38). To assess the full 
potential of these various approaches in enhancing 
ORS, data from carefully-designed and conducted 
large-scale clinical trials require to be evaluated be-
fore deciding upon their effectiveness, practicality, 
applicability, and acceptability.
Among the various factors contributing towards 
the success of ORS, the critical factors include its 
low cost, simplicity, and ease of use. Based upon 
observations that using a reduced-osmolarity ORS 
caused fewer unscheduled intravenous infusions, 
lower stool volumes, and less vomiting when com-
pared with the standard WHO-ORS (39), the WHO 
recently recommended a change in the composition 
of ORS to a low-sodium and low-glucose solution 
(40). This improvement in the effectiveness of ORS 
was achieved without compromising the cost, sim-
plicity, or ease of use. In future, further enhance-
ments of ORT will similarly depend upon a careful 
balance of clinical effectiveness, cost-effectiveness, 
safety, public-health benefits, and ease of use.
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